论文部分内容阅读
用一种抗癌、低毒并具有栓塞作用的油性中药抗癌剂 OCC 经肝动脉栓塞治疗肝癌。对治疗一年以上的54例进行了疗效随访分析。肿瘤平均缩小率9.2%,治后一年以上生存率72%;2年以上生存率29.4%。这一结果优于目前化
An anti-cancer, anti-cancer, anti-cancer drug OCC with an anti-cancer, low-toxic and embolic effect was used to treat liver cancer by hepatic artery embolization. The efficacy of follow-up analysis was performed on 54 patients treated for more than one year. The average reduction rate of tumor was 9.2%, and the survival rate was over 72% after treatment for more than one year; the survival rate was 29.4% over 2 years. This result is better than current